未产妇药物流产对再次妊娠结局的影响

为探讨未产妇药物流产对再次妊娠结局的影响 ,采用前瞻性调查方法对本次妊娠前有药物流产史的妇女 12 8例与同期有人工流产史妇女 2 46例及无流产史的妇女 2 5 8例进行比较 ,随访妊娠分娩结局。结果表明 :因胎盘原因所产生的妊娠及分娩并发症发生率和先兆流产、早产发生率药物流产组明显低于人工流产组 (P <0 .0 1) ,与无流产组差异无显著性 (P >0 .0 5 )。产后出血发生率 ,药物流产组亦明显低于人工流产组 (P <0 .0 5 ) ,与无流产组差异无显著性 (P >0 .0 5 )。提示未产妇女药物流产后再次妊娠分娩时产科并发症的发生率与无流产者相比未见增加 ,与人工流产者相比 ,有较大的安全性

Effect of Drug-Abortion on repregnancy in nulliparas

In order to investigate the effect of drug abortion on repregnancy in nulliparas, 128 women with a drug-abortion history before this pregnancy were prospectively studied and compared to 246 women with an induced abortion history in the same period and also compared with 258 women without abortion history. The follow-up of delivery was also evaluted. Results showed that in the drug-abortion group, the pregnancy and labor complication incidence resulted from placenta diseases, and the incidence of threatened abortion and premature labor were statisticaly lower than those in the induced abortion group (P<0.01), and there was no significant difference in comparison to those in the non-abortion group (P>0.05). The incidence of postpartum bleeding in the drug-abortion group was obviously lower than that in the induced abortion group (P<0.05). This study indicates that drug abortion is more safe than induced abortion.